The market has witnessed several product launches and approvals in the recent years. For instance, in July 2016, Abbott Laboratories received FDA approval for Absorb bioresorbable heart stent. Absorb is a fully dissolvable stent for treatment of coronary artery diseases. This product launch not only enhanced the company’ s vascular business, but also provided a better treatment option for blocked vessels of heart.
Purchase a copy of this report @ http:// www. orbisresearch. com / contact / purchase / 220775. Key Benefits:
The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets. The report provides a quantitative analysis for the period of 2014 – 2022 to enable stakeholders to capitalize on the prevailing market opportunities. Extensive analysis of the market based on product helps understand the type of devices used for treating blockages associated with chronic diseases. Competitive intelligence highlights the business practices followed by leading players across various regions. Comprehensive analysis of all geographic regions helps determine the prevailing opportunities in these regions. Key market players and their strategies are analyzed to understand the competitive outlook of the global market. Extensive analysis of the market is conducted by following key product positioning and monitoring the top contenders within the market framework.
For more information contact sales @ orbisresearch. com
Some Point’ s from Table of Content:
Chapter 1 Introduction 1.1 Report description 1.2 Key benefits 1.3 Key market segments 1.4 Key players 1.5 Research methodology 1.5.1 Secondary research 1.5.2 Primary research 1.5.3 Analyst tools and models
Chapter 2 Executive Summary 2.1 CXO perspective
Chapter 3 Market Overview 3.1 Market definition and scope 3.2 Key findings 3.2.1 Top investment pockets
3